Bank of Nova Scotia Trust’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.18M | Sell |
27,681
-124
| -0.4% | -$36.8K | 0.7% | 35 |
|
|
2025
Q4 | $7.59M | Buy |
27,805
+794
| +3% | +$216K | 0.66% | 38 |
|
|
2025
Q3 | $7.3M | Sell |
27,011
-94
| -0.3% | -$25.6K | 0.68% | 39 |
|
|
2025
Q2 | $7.47M | Buy |
27,105
+1,285
| +5% | +$349K | 0.74% | 39 |
|
|
2025
Q1 | $6.85M | Buy |
25,820
+1,201
| +5% | +$296K | 0.73% | 40 |
|
|
2024
Q4 | $5.72M | Buy |
24,619
+1,817
| +8% | +$418K | 0.6% | 42 |
|
|
2024
Q3 | $5.03M | Buy |
22,802
+2,098
| +10% | +$434K | 0.51% | 44 |
|
|
2024
Q2 | $4.07M | Buy |
20,704
+4,106
| +25% | +$848K | 0.45% | 47 |
|
|
2024
Q1 | $3.57M | Buy |
16,598
+5,828
| +54% | +$1.22M | 0.38% | 51 |
|
|
2023
Q4 | $2.27M | Buy |
10,770
+2,974
| +38% | +$635K | 0.25% | 57 |
|
|
2023
Q3 | $1.56M | Buy |
7,796
+81
| +1% | +$16.1K | 0.19% | 64 |
|
|
2023
Q2 | $1.43M | Buy |
7,715
+1,798
| +30% | +$332K | 0.15% | 67 |
|
|
2023
Q1 | $1.13M | Buy |
5,917
+4,007
| +210% | +$725K | 0.12% | 74 |
|
|
2022
Q4 | $321K | Sell |
1,910
-71
| -4% | -$12.3K | 0.03% | 118 |
|
|
2022
Q3 | $351K | Buy |
1,981
+24
| +1% | +$4.74K | 0.04% | 106 |
|
|
2022
Q2 | $401K | Buy |
1,957
+19
| +1% | +$4.03K | 0.04% | 105 |
|
|
2022
Q1 | $461K | Sell |
1,938
-1
| -0.1% | -$235 | 0.04% | 107 |
|
|
2021
Q4 | $443K | Sell |
1,939
-165
| -8% | -$36.3K | 0.04% | 105 |
|
|
2021
Q3 | $407K | Buy |
2,104
+2
| +0.1% | +$405 | 0.04% | 101 |
|
|
2021
Q2 | $447K | Sell |
2,102
-80
| -4% | -$16.9K | 0.04% | 101 |
|
|
2021
Q1 | $446K | Buy |
2,182
+18
| +0.8% | +$3.54K | 0.04% | 100 |
|
|
2020
Q4 | $394K | Buy |
2,164
+36
| +2% | +$6.12K | 0.04% | 100 |
|
|
2020
Q3 | $356K | Buy |
2,128
+67
| +3% | +$11.3K | 0.04% | 88 |
|
|
2020
Q2 | $335K | Buy |
2,061
+404
| +24% | +$72.4K | 0.05% | 80 |
|
|
2020
Q1 | $287K | Sell |
1,657
-221
| -12% | -$44K | 0.04% | 87 |
|
|
2019
Q4 | $377K | Buy |
1,878
+156
| +9% | +$32K | 0.04% | 87 |
|
|
2019
Q3 | $364K | Sell |
1,722
-83
| -5% | -$17.3K | 0.04% | 83 |
|
|
2019
Q2 | $350K | Hold |
1,805
| – | – | 0.04% | 87 |
|
|
2019
Q1 | $297K | Sell |
1,805
-38
| -2% | -$6.72K | 0.04% | 93 |
|
|
2018
Q4 | $347K | Buy |
+1,843
| New | +$340K | 0.05% | 86 |
|
|
2017
Q4 | – | Sell |
-1,213
| Closed | -$165K | – | 179 |
|
|
2017
Q3 | $165K | Buy |
+1,213
| New | +$153K | 0.02% | 144 |
|
Other funds holding CME
VCM
VPM
Bank of Nova Scotia Trust's CME Position: Q1 2026 in Review
Bank of Nova Scotia Trust reduced its CME Group (CME) stake by 0.45% in Q1 2026, selling an estimated $36.8K and leaving 27,681 shares worth $8.18M. The position accounts for 0.7% of the portfolio, ranked #35.
Bank of Nova Scotia Trust first reported a position in CME in Q3 2017 and has held it in 31 quarters since. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Bank of Nova Scotia Trust held 27,681 shares of CME Group worth $8.18M as of Q1 2026.
- Bank of Nova Scotia Trust sold 124 CME Group shares in Q1 2026, an estimated $36.8K.
- CME Group made up 0.7% of Bank of Nova Scotia Trust's portfolio in Q1 2026, its #35 holding.
- Bank of Nova Scotia Trust first reported a position in CME Group in Q3 2017 and has held it in 31 quarters since.
- 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Bank of Nova Scotia Trust's 13F filing for Q1 2026, filed 13 May 2026.